|
|
Blood, 1 March 2005, Vol. 105, No. 5, pp. 2042-2048.
Prepublished online as a Blood First Edition Paper on October 28, 2004; DOI 10.1182/blood-2004-04-1299.
Previous Article | Next Article 
Submitted April 8, 2004
Accepted October 24, 2004
Nonsteroidal anti-inflammatory drugs inhibit a FYN dependent pathway coupled to RAC and stress kinase activation in TCR signaling
Silvia R Paccani, Laura Patrussi, Cristina Ulivieri, Jaime L Masferrer, Mario M D'Elios, and Cosima T Baldari*
Department of Evolutionary Biology, University of Siena, Siena, Italy
Oncology Discovery Research, Pfizer Corporation, St. Louis, Missouri, USA
Department of Internal Medicine and Immunoallergology, University of Florence, Florence, Italy
* Corresponding author; email: baldari{at}unisi.it.
In addition to their anti-inflammatory properties, nonsteroidal anti-inflammatory drugs (NSAID) harbour immunosuppressive activities, related to their capacity both to inhibit cyclooxygenases (COX) and to act as PPAR ligands. We have previously shown that the stress-activated kinase p38 is a selective target of NSAID in T cells. Here we have investigated the effect of NSAID on the signaling pathway triggered by the T cell antigen receptor (TCR) and leading to stress kinase activation. The results show that nonselective and COX-1 selective NSAID also block activation of the stress kinase JNK, and that PGE2 reverses this block and enhances TCR dependent JNK activation. Analysis of the activation state of the components upstream of p38 and JNK showed that NSAID inhibit the serine-threonine kinase Pak1 and the small GTPase Rac, as well as the Rac specific guanine nucleotide exchanger, Vav. Furthermore, activation of Fyn, which controls Vav phosphorylation, is inhibited by NSAID, while activation of Lck and of the Lck-dependent tyrosine kinase cascade is unaffacted. Accordingly, constitutively active Fyn reverses the NSAID dependent stress kinase inhibition. The data identify COX-1 as an important early modulator of TCR signaling and highlight a TCR proximal pathway selectively coupling the TCR to stress kinase activation.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
V. A. Blaho, M. W. Buczynski, E. A. Dennis, and C. R. Brown
Cyclooxygenase-1 Orchestrates Germinal Center Formation and Antibody Class-Switch via Regulation of IL-17
J. Immunol.,
November 1, 2009;
183(9):
5644 - 5653.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Patrussi, C. Ulivieri, O. M. Lucherini, S. R. Paccani, A. Gamberucci, L. Lanfrancone, P. G. Pelicci, and C. T. Baldari
p52Shc is required for CXCR4-dependent signaling and chemotaxis in T cells
Blood,
September 15, 2007;
110(6):
1730 - 1738.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Gasser, T. A. Schmid, G. Zenhaeusern, and C. Hess
Cyclooxygenase Regulates Cell Surface Expression of CXCR3/1-Storing Granules in Human CD4+ T Cells
J. Immunol.,
December 15, 2006;
177(12):
8806 - 8812.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|